A seal-forming structure for a patient interface may include a patient-contacting surface configured to engage the patient's facial skin to form a seal; a posterior opening formed in the patient-contacting surface, the posterior opening configured to provide the flow of air at said therapeutic pressure to the patient's nares; and a support structure extending from the patient contacting surface to an interior surface of the seal-forming structure, the support structure and the interior surface forming a continuous loop, wherein the patient interface is configured to allow the patient to breath from ambient through their mouth in the absence of a flow of pressurised air through the plenum chamber inlet port, or the patient interface is configured to leave the patient's mouth uncovered.

A breathable gas inlet control device permits flow regulation at the inlet of a flow generator for a respiratory treatment apparatus such as a ventilator or continuous positive airway pressure device. The device may implement a variable inlet aperture size based on flow conditions. In one embodiment, an inlet flow seal opens or closes the inlet to a blower in accordance with changes in pressure within a seal activation chamber near the seal. The seal may be formed by a flexible membrane. A controller selectively changes the pressure of the seal activation chamber by controlling a set of one or more flow control valves to selectively stop forward flow, prevent back flow or lock open the seal to permit either back flow or forward flow. The controller may set the flow control valves as a function of detected respiratory conditions based on data from pressure and/or flow sensors.

According to an aspect, there is provided a cannula for use in high flow nasal therapy, comprising: a first tube for directing a first fluid from a nasal cavity of a subject to a location outside of the subject; a second tube for directing a second fluid from a supply of the second fluid to the nasal cavity of the subject; a flow sensor located within the first tube, the flow sensor configured to measure a flow rate of the first fluid moving through the first tube; and a humidity sensor located within the first tube, the humidity sensor configured to measure a humidity of the first fluid moving through the first tube; wherein the measured flow rate and the measured humidity are to be used by a processor to control a humidifier to adjust a humidity of the second fluid to be supplied to the subject.

According to some embodiments there is provided a device configured for releasing at least one substance from source material, comprising: a housing; a plurality of source material sections positioned at fixed locations with respect to the housing; a plurality of airflow paths, each airflow path associated with at least one source material section; each airflow path associated with at least one blocking element which prevents flow of air through the path; and an actuator operably coupled to the blocking element, the actuator configured for unblocking the airflow path of at least one selected source material section to allow flow of air to and through source material within the selected section.

A seal-forming structure for a patient interface may include a patient-contacting surface configured to engage the patient’s facial skin to form a seal; a posterior opening formed in the patient-contacting surface, the posterior opening configured to provide the flow of air at said therapeutic pressure to the patient’s nares; and a support structure extending from the patient contacting surface to an interior surface of the seal-forming structure, the support structure and the interior surface forming a continuous loop, wherein the patient interface is configured to allow the patient to breath from ambient through their mouth in the absence of a flow of pressurised air through the plenum chamber inlet port, or the patient interface is configured to leave the patient’s mouth uncovered.

A fluid delivery system provides fluid, such as supplement oxygen, to a patient in response to inhalation. The fluid delivery system includes a valve assembly that is triggered by sensing onset of inspiration by measuring a change in temperature or fluid flow of air flow in a nasal or oral cannula, mask or helmet.

A breathable gas inlet control device permits flow regulation at the inlet of a flow generator for a respiratory treatment apparatus such as a ventilator or continuous positive airway pressure device. The device may implement a variable inlet aperture size based on flow conditions. In one embodiment, an inlet flow seal opens or closes the inlet to a blower in accordance with changes in pressure within a seal activation chamber near the seal. The seal may be formed by a flexible membrane. A controller selectively changes the pressure of the seal activation chamber by controlling a set of one or more flow control valves to selectively stop forward flow, prevent back flow or lock open the seal to permit either back flow or forward flow. The controller may set the flow control valves as a function of detected respiratory conditions based on data from pressure and/or flow sensors.

The systems and methods provide for novel a triggering mode that allows the patient to trigger or initiate the delivery of a breath during ventilation on a ventilator. Further, the systems and methods provide for triggering ventilation utilizing a statistical trigger mode. Additionally, the systems and methods provide for analyzing and/or displaying information related to a potential change in a triggering threshold for a currently utilized breath type.

This description provides risk notifications for a geographic region to inform patients and effect behavior changes to prevent rescue events and exacerbations from occurring. A risk analysis for a geographic region is based on data gathered from a population of patients who may experience respiratory events within the geographic region. Rescue medication events, environmental conditions relevant to the rescue medication events, and other contextually relevant information are detected by sensors associated with a population of patients' medicament device/s and are collected from other sources, respectively, to provide a basis to determine a risk score. This data is analyzed to determine the severity of the risk of a respiratory event occurring within a geographical region and accordingly sending a notification to patients within that geographical region.

A vibration conveyor is provided for a capsule-based, single-dose dry powder inhaler of the type comprising an inhaler body comprising a capsule chamber for receiving a dry powder formulation capsule, an inhalation channel in fluid communication with the chamber, and means for piercing a capsule in the chamber to allow outside air flow to be mixed with the contents of said capsule for inhalation thereof, means for monitoring vibrations resulting from inhalation, and means for transferring said vibrations from the inhaler body to the monitoring means. The conveyor comprises a plate interposed between the body and the means for monitoring.